UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 245

Sortiert nach

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Cancer, 2006-04, Vol.106 (7), p.1569-1580

2006

Volltextzugriff (PDF)

Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm

Nature genetics, 1997-05, Vol.16 (1), p.74-78

1997

Volltextzugriff (PDF)

Chemotherapy With Dexamethasone, High-Dose Cytarabine, and Cisplatin for Parenchymal Brain Lymphoma

JNCI : Journal of the National Cancer Institute, 1988-11, Vol.80 (17), p.1408-1412

1988

Volltextzugriff (PDF)

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma

Blood, 1992-02, Vol.79 (4), p.1024-1028

1992

Volltextzugriff (PDF)

Clinical Implications of PET-Negative Residual CT Masses after Chemotherapy for Diffuse Large B-Cell Lymphoma

Leukemia & lymphoma, 2013-05, Vol.54 (12)

2013

Volltextzugriff (PDF)

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma

Leukemia & lymphoma, 2013-12, Vol.54 (12), p.2631-2638

2013

Volltextzugriff (PDF)

The Clinical Outcome of Newly Diagnosed Patients >60 Years of Age with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Standard or Liposomal Chemotherapies

Blood, 2015-12, Vol.126 (23), p.3965-3965

2015

Volltextzugriff (PDF)

Clinicopathologic features and outcomes of de novo transformed indolent lymphoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.8061-8061

2020

Volltextzugriff (PDF)

Combination treatment approaches and novel therapies for lymphoma

Clinical advances in hematology & oncology, 2007-08, Vol.5 (8 Suppl 12), p.4

2007

Volltextzugriff (PDF)

Combined modality therapy in stage III and stage IIIE diffuse large cell lymphomas

Cancer, 1984-04, Vol.53 (7), p.1478-1483

1984

Volltextzugriff (PDF)

Comparison of the international prognostic factors index (IPI) with the absolute monocyte and lymphocyte prognostic index (AMLPI) for patients (Pts) with diffuse large b-cell lymphoma (DLBCL) receiving R-CHOP

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.8067-8067

2012

Volltextzugriff (PDF)

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

Blood cancer journal (New York), 2022-02, Vol.12 (2), p.25-25, Article 25

2022

Volltextzugriff (PDF)

Diagnosis and management of Hodgkin's disease in the adult

Cancer, 1983-06, Vol.51 (S12), p.2469-2476

1983

Volltextzugriff (PDF)

Differential JAK-STAT Pathway Activation in Primary Mediastinal Large B-Cell Lymphoma: Two Subgroups with Differential Cytokine Activation Patterns and Predicted Responses to Kinase Inhibitors

Blood, 2009-11, Vol.114 (22), p.968-968

2009

Volltextzugriff (PDF)

Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse

Journal of clinical oncology, 1991-02, Vol.9 (2), p.236-242

1991

Volltextzugriff (PDF)

Dose adjusted‐EPOCH‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma

British journal of haematology, 2017-11, Vol.179 (3), p.503-506

2017

Volltextzugriff (PDF)

Dose‐Adjusted EPOCH‐R and Mid‐Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement

British journal of haematology, 2017-12, Vol.179 (5), p.851-854

2017

Volltextzugriff (PDF)

Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondaryCNS Involvement

British journal of haematology, 2017-12, Vol.179 (5), p.851

2017

Volltextzugriff (PDF)

Dose-Related Safety and Immunogenicity of Baculovirus-Expressed Trivalent Influenza Vaccine: A Double-Blind, Controlled Trial in Adult Patients with Non-Hodgkin B Cell Lymphoma

The Journal of infectious diseases, 2006-11, Vol.194 (10), p.1394-1397

2006

Volltextzugriff (PDF)

Double Epigenetic Modulation of High-Dose Chemotherapy (HDC) with Autologous Stem-Cell Transplant (ASCT) for Patients with Refractory or Poor-Risk Relapsed Lymphoma

Blood, 2015-12, Vol.126 (23), p.1992-1992

2015

Volltextzugriff (PDF)

Double Hit Lymphoma: M.D. Anderson Experience

Blood, 2013-11, Vol.122 (21), p.1776-1776

2013

Volltextzugriff (PDF)

Double hit lymphoma: the MD A nderson C ancer C enter clinical experience

British journal of haematology, 2014-09, Vol.166 (6), p.891-901

2014

Volltextzugriff (PDF)

26 – 50 von 245

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(220)

Publikationsform

Artikel
(244)
Buchkapitel
(1)

Sprache

Englisch
(245)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(133)
Life Sciences & Biomedicine
(132)
Humans
(128)
Oncology
(89)
Middle Aged
(79)
Male
(78)
Adult
(75)
Female
(73)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(65)
Aged
(64)
Biological And Medical Sciences
(64)
Medical Sciences
(64)
Hematology
(63)
Treatment Outcome
(43)
Prognosis
(39)
Neoplasm Staging
(36)
Hematologic And Hematopoietic Diseases
(32)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(31)
Chemotherapy
(31)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL

Chemoimmunotherapy with hyper‐CVAD plus rituximab for the treatment of adult Burkitt and Burkitt‐type lymphoma or acute lymphoblastic leukemia

Chemotherapy-Free Induction with Ibrutinib-Rituximab Followed By Shortened Cycles of Chemo-Immunotherapy Consolidation in Young, Newly Diagnosed Mantle Cell Lymphoma Patients: A Phase II Clinical Trial

Chemotherapy induces transient sex chromosomal and autosomal aneuploidy in human sperm

Chemotherapy With Dexamethasone, High-Dose Cytarabine, and Cisplatin for Parenchymal Brain Lymphoma

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

Clinical, biologic, and histologic features of late relapses in diffuse large cell lymphoma

Clinical Implications of PET-Negative Residual CT Masses after Chemotherapy for Diffuse Large B-Cell Lymphoma

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma

The Clinical Outcome of Newly Diagnosed Patients >60 Years of Age with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Standard or Liposomal Chemotherapies

Clinicopathologic features and outcomes of de novo transformed indolent lymphoma

Combination treatment approaches and novel therapies for lymphoma

Combined modality therapy in stage III and stage IIIE diffuse large cell lymphomas

Comparison of the international prognostic factors index (IPI) with the absolute monocyte and lymphocyte prognostic index (AMLPI) for patients (Pts) with diffuse large b-cell lymphoma (DLBCL) receiving R-CHOP

Determining clinical course of diffuse large B-cell lymphoma using targeted transcriptome and machine learning algorithms

Diagnosis and management of Hodgkin's disease in the adult

Differential JAK-STAT Pathway Activation in Primary Mediastinal Large B-Cell Lymphoma: Two Subgroups with Differential Cytokine Activation Patterns and Predicted Responses to Kinase Inhibitors

Discordant bone marrow involvement in diffuse large-cell lymphoma: a distinct clinical-pathologic entity associated with a continuous risk of relapse

Dose adjusted‐EPOCH‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma

Dose‐Adjusted EPOCH‐R and Mid‐Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondary CNS Involvement

Dose-Adjusted EPOCH-R and Mid-Cycle High Dose Methotrexate for Patients with Systemic Lymphoma and secondaryCNS Involvement

Dose-Related Safety and Immunogenicity of Baculovirus-Expressed Trivalent Influenza Vaccine: A Double-Blind, Controlled Trial in Adult Patients with Non-Hodgkin B Cell Lymphoma

Double Epigenetic Modulation of High-Dose Chemotherapy (HDC) with Autologous Stem-Cell Transplant (ASCT) for Patients with Refractory or Poor-Risk Relapsed Lymphoma

Double Hit Lymphoma: M.D. Anderson Experience

Double hit lymphoma: the MD A nderson C ancer C enter clinical experience

Suchergebnisse filtern